Improving efficiency of ALS clinical trials: a sponsor's perspective

Amyotroph Lateral Scler Other Motor Neuron Disord. 2002:3 Suppl 1:S7-8. doi: 10.1080/146608202320374138.
No abstract available

MeSH terms

  • Amyotrophic Lateral Sclerosis / drug therapy*
  • Biomarkers
  • Clinical Trials as Topic*
  • Dose-Response Relationship, Drug
  • Humans
  • Research Design

Substances

  • Biomarkers